X0609 4 2026-09-15 0001880438 AN2 Therapeutics, Inc. ANTX 0002150478 Trenor Cameron C. III false C/O AN2 THERAPEUTICS, INC. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA 94025 false true false false Chief Medical Officer false Common Stock 2026-09-15 4 A false 116667 0 A 116667 D Stock Option (right to by) 5.36 2026-09-15 4 A false 233333 0 A 2036-09-14 Common Stock 233333 233333 D Represents restricted stock units ("RSUs") which vest as follows: 10,400 RSUs vest on January 1, 2027, prorated from August 24, 2026, the vesting start date, and the remaining RSUs vest in equal annual installments on each January 1, 2028, January 1, 2029 and January 1, 2030, subject to the Reporting Person's continuous service through each applicable vesting date. The shares subject to the stock option vest as follows: 25% of the shares vest on August 24, 2027 and the remaining shares vest in equal monthly installments over the subsequent 36 months, subject to the Reporting Person's continuous service through each applicable vesting date. /s/ Eric Easom, Attorney-in-Fact for Cameron Trenor 2026-09-16